WallStreetZenWallStreetZen

NASDAQ: AMGN
Amgen Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for AMGN

Based on 9 analysts offering 12 month price targets for Amgen Inc

Min Forecast
$280.00-3.75%
Avg Forecast
$316.56+8.81%
Max Forecast
$380.00+30.62%

Should I buy or sell AMGN stock?

Based on 9 analysts offering ratings for Amgen Inc.

Buy
Strong Buy
2 analysts 22.22%
Buy
1 analysts 11.11%
Hold
5 analysts 55.56%
Sell
1 analysts 11.11%
Strong Sell
0 analysts 0%
Although AMGN's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates AMGN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their AMGN stock forecasts and price targets.

AMGN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-14
lockedlocked$00.00+00.00%2025-04-09
lockedlocked$00.00+00.00%2025-03-05
lockedlocked$00.00+00.00%2025-02-10
lockedlocked$00.00+00.00%2025-01-28
RBC Capital
Top 8%
93
BuyReiterates$324.00+11.37%2025-01-24
Wells Fargo
Top 12%
89
HoldMaintains$280.00-3.75%2025-01-10
Truist Securities
Bottom 15%
15
HoldMaintains$298.00+2.43%2025-01-08
Jefferies
Top 21%
80
Strong BuyMaintains$380.00+30.62%2024-11-12

1 of 1

Forecast return on equity

Is AMGN forecast to generate an efficient return?

Company
204.29%
Industry
227.09%
Market
80.27%
AMGN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AMGN forecast to generate an efficient return on assets?

Company
13.07%
Industry
27.8%
AMGN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AMGN earnings per share forecast

What is AMGN's earnings per share in the next 3 years based on estimates from 15 analysts?

Avg 1 year Forecast
$20.57+169.92%
Avg 2 year Forecast
$21.11+177%
Avg 3 year Forecast
$22.19+191.26%
AMGN's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

AMGN revenue forecast

What is AMGN's revenue in the next 3 years based on estimates from 11 analysts?

Avg 1 year Forecast
$35.0B+4.68%
Avg 2 year Forecast
$35.6B+6.55%
Avg 3 year Forecast
$36.6B+9.63%
AMGN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AMGN earnings growth forecast

How is AMGN forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
42.58%
Industry
44.96%
Market
17.59%
AMGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
AMGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
AMGN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

AMGN revenue growth forecast

How is AMGN forecast to perform vs Drug Manufacturers - General companies and vs the US market?

Company
3.04%
Industry
8.71%
Market
10.07%
AMGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AMGN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AMGN vs General Drug Manufacturer Stocks

TickerPricePrice TargetUp/downsideConsensus
AMGN$290.92$316.56+8.81%Buy
SNY$54.95$65.00+18.29%Hold
PFE$24.41$27.78+13.80%Hold
GILD$106.54$112.11+5.22%Buy
BMY$50.20$60.00+19.52%Hold
View Top General Drug Manufacturer Stocks

Amgen Stock Forecast FAQ

Is Amgen Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NASDAQ: AMGN) stock is to Buy AMGN stock.

Out of 9 analysts, 2 (22.22%) are recommending AMGN as a Strong Buy, 1 (11.11%) are recommending AMGN as a Buy, 5 (55.56%) are recommending AMGN as a Hold, 1 (11.11%) are recommending AMGN as a Sell, and 0 (0%) are recommending AMGN as a Strong Sell.

If you're new to stock investing, here's how to buy Amgen stock.

What is AMGN's earnings growth forecast for 2025-2027?

(NASDAQ: AMGN) Amgen's forecast annual earnings growth rate of 42.58% is not forecast to beat the US Drug Manufacturers - General industry's average forecast earnings growth rate of 44.96%, and while it is forecast to beat the US market's average forecast earnings growth rate of 17.59%.

Amgen's earnings in 2025 is $4,090,000,000.On average, 15 Wall Street analysts forecast AMGN's earnings for 2025 to be $11,049,070,106, with the lowest AMGN earnings forecast at $10,781,703,206, and the highest AMGN earnings forecast at $11,415,605,039. On average, 13 Wall Street analysts forecast AMGN's earnings for 2026 to be $11,338,838,452, with the lowest AMGN earnings forecast at $10,459,380,240, and the highest AMGN earnings forecast at $12,457,782,628.

In 2027, AMGN is forecast to generate $11,922,672,784 in earnings, with the lowest earnings forecast at $10,840,795,750 and the highest earnings forecast at $13,634,261,453.

What is AMGN's revenue growth forecast for 2025-2027?

(NASDAQ: AMGN) Amgen's forecast annual revenue growth rate of 3.04% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 8.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.07%.

Amgen's revenue in 2025 is $33,424,000,000.On average, 11 Wall Street analysts forecast AMGN's revenue for 2025 to be $18,795,780,266,178, with the lowest AMGN revenue forecast at $18,426,129,544,900, and the highest AMGN revenue forecast at $19,227,442,702,847. On average, 11 Wall Street analysts forecast AMGN's revenue for 2026 to be $19,131,372,194,070, with the lowest AMGN revenue forecast at $18,483,073,268,858, and the highest AMGN revenue forecast at $19,963,634,803,193.

In 2027, AMGN is forecast to generate $19,685,393,800,606 in revenue, with the lowest revenue forecast at $18,967,094,922,501 and the highest revenue forecast at $21,115,589,148,306.

What is AMGN's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: AMGN) forecast ROA is 13.07%, which is lower than the forecast US Drug Manufacturers - General industry average of 27.8%.

What is AMGN's Price Target?

According to 9 Wall Street analysts that have issued a 1 year AMGN price target, the average AMGN price target is $316.56, with the highest AMGN stock price forecast at $380.00 and the lowest AMGN stock price forecast at $280.00.

On average, Wall Street analysts predict that Amgen's share price could reach $316.56 by Apr 14, 2026. The average Amgen stock price prediction forecasts a potential upside of 8.81% from the current AMGN share price of $290.92.

What is AMGN's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: AMGN) Amgen's current Earnings Per Share (EPS) is $7.62. On average, analysts forecast that AMGN's EPS will be $20.57 for 2025, with the lowest EPS forecast at $20.07, and the highest EPS forecast at $21.25. On average, analysts forecast that AMGN's EPS will be $21.11 for 2026, with the lowest EPS forecast at $19.47, and the highest EPS forecast at $23.19. In 2027, AMGN's EPS is forecast to hit $22.19 (min: $20.18, max: $25.38).

What is AMGN's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: AMGN) forecast ROE is 204.29%, which is considered strong.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.